These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 17452016)

  • 1. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis.
    Opal SM
    Int J Med Microbiol; 2007 Sep; 297(5):365-77. PubMed ID: 17452016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxins and other sepsis triggers.
    Opal SM
    Contrib Nephrol; 2010; 167():14-24. PubMed ID: 20519895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis and septic shock.
    Zanetti G; Baumgartner JD; Glauser MP
    Schweiz Med Wochenschr; 1997 Mar; 127(12):489-99. PubMed ID: 9106949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxin as a drug target.
    Opal SM; Glück T
    Crit Care Med; 2003 Jan; 31(1 Suppl):S57-64. PubMed ID: 12544978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.
    Morrison DC; Bucklin SE
    Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic effects of endotoxin.
    Zivot JB; Hoffman WD
    New Horiz; 1995 May; 3(2):267-75. PubMed ID: 7583168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin as a therapeutic target in septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):35-43. PubMed ID: 8162352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
    Ohlsson K; Björk P; Bergenfeldt M; Hageman R; Thompson RC
    Nature; 1990 Dec; 348(6301):550-2. PubMed ID: 2147233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic therapeutic requirements in the treatment of sepsis in acute renal failure.
    Cambi V; David S
    Nephrol Dial Transplant; 1994; 9 Suppl 4():183-6. PubMed ID: 7800255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new method for removing endotoxin from plasma using hemocompatible affinity chromatography technology, applicable for extracorporeal treatment of septic patients.
    Amoureux MC; Hegyi E; Le D; Grandics P; Tong H; Szathmary S
    J Endotoxin Res; 2004; 10(2):85-95. PubMed ID: 15119999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current prospects for the treatment of clinical sepsis.
    Suffredini AF
    Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalized dendrimers as endotoxin sponges.
    Cromer JR; Wood SJ; Miller KA; Nguyen T; David SA
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1295-8. PubMed ID: 15713373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting bacterial endotoxin: two sides of a coin.
    Bosshart H; Heinzelmann M
    Ann N Y Acad Sci; 2007 Jan; 1096():1-17. PubMed ID: 17405910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lysosomal enzymes in experimental and clinical endotoxemia.
    Godin DV; Wright JM; Tuchek JM; Scudamore CH
    Clin Invest Med; 1983; 6(4):319-25. PubMed ID: 6671362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of endotoxin antagonism.
    Lazaron V; Dunn DL
    World J Surg; 2002 Jul; 26(7):790-8. PubMed ID: 11948366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an anti-core lipopolysaccharide vaccine for the prevention and treatment of sepsis.
    Cross AS; Opal S; Cook P; Drabick J; Bhattacharjee A
    Vaccine; 2004 Feb; 22(7):812-7. PubMed ID: 15040932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombin: prospects in clinical practice. Sespsi: anticoagulant or anti-inflammatory agents?].
    Imberti D
    Minerva Anestesiol; 2003 May; 69(5):371-5. PubMed ID: 12768169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
    Morrison DC
    Prog Clin Biol Res; 1998; 397():199-207. PubMed ID: 9575560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice.
    Nakamura M; Shimizu Y; Sato Y; Miyazaki Y; Satoh T; Mizuno M; Kato Y; Hosaka Y; Furusako S
    Eur J Pharmacol; 2007 Aug; 569(3):237-43. PubMed ID: 17588563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.